Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • SylvainL
    Senior Member
    • Feb 2012
    • 180

    featureCounts

    Hi all,

    I am using (for the first time) featureCounts to get gene level counts in a RNAseq experiment... It is mouse RNAseq and polyA RNA were extracted...

    A quick look at the results shows up to 15% of reads which are unassigned because of no overlap with any feature.

    Do you normally have the same stats?

    s.
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    I just checked one dataset (mouse liver), where ~5% had no feature, ~3% were ambiguously mapped (a non-stranded protocol), and ~19% were not uniquely mapped. ~75% were counted if we exclude unmapped reads. This is similar in a mouse hippocampus dataset that I just checked. Obviously if you include unmapped reads then these percentages would go down a bit.

    So, that unassigned percentage seems a bit high, but perhaps there's a good biological reason for that (e.g., in tumors or sperm).

    Comment

    • GenoMax
      Senior Member
      • Feb 2008
      • 7142

      #3
      Post #29. Response from Wei Shi (author of featureCounts): http://seqanswers.com/forums/showthr...t=49506&page=2

      Comment

      • SylvainL
        Senior Member
        • Feb 2012
        • 180

        #4
        Hi dpryan,

        I already removed the non uniquely mapped so yes, it's a bit lower if we consider all the mapped reads... and yes, it's sperm...

        So I should not worry :9

        Thanks a lot

        Comment

        • dpryan
          Devon Ryan
          • Jul 2011
          • 3478

          #5
          Yeah, sperm will inherently be different, since you have depletion of mRNAs. My sperm datasets aren't polyA enriched, they're ribo-depleted, so I don't have any numbers for comparison.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM
          • GATTACAT
            Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
            by GATTACAT
            Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
            07-01-2026, 11:43 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          15 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-09-2026, 10:04 AM
          0 responses
          29 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-08-2026, 10:08 AM
          0 responses
          16 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-07-2026, 11:05 AM
          0 responses
          33 views
          0 reactions
          Last Post SEQadmin2  
          Working...